Dr Barbara Shacklett, PhD, is Professor of Microbiology and Immunology at the University of California, Davis. Her laboratory is recognized for developing and applying innovative approaches to study mucosal immunity to HIV. Over the past 10 years, her work has helped elucidate the relationship between mucosal T-cell responses and immune control of HIV infection, both in human cohorts and in the nonhuman primate model (SIVmac). This work has included studies of HIV “Elite” Controllers, the role of mucosal regulatory T-cells (Treg), mucosal immune reconstitution in individuals on combination antiretroviral therapy (cART), and mucosa-associated invariant T-cells (MAIT cells). Her group also studies the female reproductive tract, including hormonal regulation of innate and adaptive immune responses and the impact of menstrual cycle phases on host defense. She has coauthored over 80 peer-reviewed publications, served on grant review panels in the US, France, and Canada, and is currently an Associate Editor of Mucosal Immunology.

Dr Jenny Anderson is a Senior Scientist in Prof Sharon Lewin and Assoc Prof Paul Cameron's laboratory at the Doherty Institute at the University of Melbourne. Since 2012, she has studied HIV persistence in resting CD4+ T-cell subsets in HIV+ individuals on ART and new strategies to purge persistent HIV.

Dr McMahon is an Infectious Diseases physician and Head of Clinical Research at the Alfred Hospital, an ID physician at Monash Medical Centre and Chairs the ASHM ARV Guidelines Committee. His research interests are in HIV Cure-focused clinical trials, antiretroviral therapy and methods to maximise retention in HIV care.

Dr. Jennifer Zerbato is a post-doctoral research fellow in the laboratory of Professor Sharon Lewin and Associate Professor Paul Cameron. Dr. Zerbato’s research is primarily focused on HIV latency reversal strategies as well as new strategies to identify and characterize the HIV latent reservoir in individuals on ART.